Data Index


Index of Data Sources

The Behavioral Risk Factor Surveillance System (BRFSS) is a survey that is administered across the United States by the National Centers for Disease Control and Prevention to adults ages 18+. Through a telephone survey it collects data regarding health-related risk behaviors, chronic health conditions, and use of preventive services. Each year BRFSS conducts more than 400,000 adult interviews. Use the following link to explore the 2019 BRFSS Survey Data and Documentation. The primary contact for data requests is Melissa Damren, Maine BRFSS Coordinator: melissa.damren@maine.gov

The Office of the Maine Attorney General provides naloxone to over 116 local, county, and state law enforcement agencies serving all 16 counties of the state. The overdose reversal data is self-reported by participating officers and departments in the OAG program. The primary contact to administer naloxone through this program is Brian MacMaster, Chief of Investigations, Office of the Maine Attorney General: brian.macmaster@maine.gov. The primary contact for data requests is Marcella Sorg, Director, Rural Drug & Alcohol Research Program, Margaret Chase Smith Policy Center, University of Maine: mhsorg@maine.edu

The Department of Health and Human Services reports annually on the activities of all hypodermic apparatus exchange programs operating in the State of Maine. The report consists of data from November through October of the previous calendar year and data are reported to the Maine CDC from the licensed Syringe Service Programs operating in Maine. Use the following link to download the 2019 Syringe Service Programs in Maine Annual Report. The primary contact for data requests is Lauren Gauthier, Infectious Disease Prevention Director, Division of Disease Surveillance, Maine Center for Disease Control and Prevention: lauren.gauthier@maine.gov

The Maine CDC Drug Overdose Morbidity and Mortality, and Opioid Prescribing Trends in Maine website consists of a series of dashboards that provide a multi-faceted view of the drug overdose crisis in Maine. Included are confirmed drug deaths by quarter, prescription opioid and benzodiazepine trends, and patient encounters in Maine emergency departments that Maine CDC classifies as suspected unintentional overdoses. This includes both fatal and nonfatal overdoses with various classes of drugs. Use the following link to explore the Maine CDC Syndromic Surveillance Dashboard. The primary contact for data requests is: syndromic@maine.gov

The Maine Department of Corrections (MDOC) Continuous Quality Improvement (CQI) staff are responsible for the collection, analysis, and reporting of key MDOC performance measures. They promote data driven and evidence-based decision making and report data daily, monthly, and annually. Use the following link to explore MDOC Reports and Statistical Data. The primary contact for data requests is Joel Gilbert, Data & CQI Manager, Maine Department of Corrections: joel.gilbert@maine.gov

The Maine Drug Data Hub is a collaboration between several state departments, the Governor’s Office, the University of Maine and the Maine Overdose Data to Action program funded by the United States Centers for Disease Control and Prevention. The Hub aggregates state and community information and provides resources, data, and visualizations to inform Mainers about efforts to reduce the harm caused by drug use. Data is updated monthly, quarterly, and annually depending on data source reporting cadence. New data metrics are added as they become available. The primary contact for questions and requests is Daniel S. Soucier, Research Associate, Rural Drug & Alcohol Research Program, Margaret Chase Smith Policy Center, University of Maine: daniel.s.soucier@maine.edu

The Maine Drug Enforcement Agency (MDEA) is the lead agency in Maine addressing drug trafficking. The MDEA provides annual data regarding drug-related arrests. Only drugs seized for criminal charges are listed and the data does not indicate what other drug or drugs may have been seized or found at the scene. For example, a drug arrest may have occurred for the sale of fentanyl but the individual may have also been in possession of methamphetamine. One limitation to this data set is that drug enforcement activities are resource dependent and resource driven. Thus, as more or less funds become available they are mobilized against emergent and high priority substance trafficking. MDEA data is an indicator of priority substances being targeted by law enforcement as well as an indicator of what substances are in the drug supply rather than an indicator of law enforcement activity. The primary contact for data requests is Roy E. McKinney, Director, MDEA: roy.e.mckinney@maine.gov

Maine EMS is a bureau within the Department of Public Safety. Maine EMS also contracts with regional partners in six defined Maine EMS regions to help oversee training, quality assurance, medical direction and EMS system operations. Maine EMS collects data from 293 licensed service providers located across the state of Maine. The primary contract for data requests is Darren Davis, Data Coordinator, Maine Emergency Medical Services: darren.w.davis@maine.gov

The Maine Naloxone Distribution Initiative (MNDI) began ordering and distributing state-purchased naloxone to community organizations, clinical sites, and end-users throughout the State of Maine to distribute free of charge. Data regarding naloxone orders, distribution, and successful opioid reversals are self-reported by four state contracted public health and harm reduction organizations and analyzed by the Margaret Chase Smith Policy Center at the University of Maine. The primary contact for data requests is Marcella Sorg, Director, Rural Drug & Alcohol Research Program, Margaret Chase Smith Policy Center, University of Maine: mhsorg@maine.edu

The Maine Office of the Chief Medical Examiner (OCME), an office of the Maine Attorney General, investigates sudden, unexpected and violent deaths throughout the state. The OCME provides the citizens of Maine with comprehensive, scientific, forensic investigation of deaths that fall within the jurisdiction of the office. Drug death data is released on an annual, quarterly, and monthly basis regarding suspected and confirmed cases. The primary contact for data requests is Marcella Sorg, Director, Rural Drug & Alcohol Research Program, Margaret Chase Smith Policy Center, University of Maine: mhsorg@maine.edu

The Office of Child and Family Services (OCFS) supports Maine’s children and their families by providing Children’s Development, Behavioral Health, & Child Welfare Services. OCFS reports data regarding child welfare, children’s behavioral health, and childhood education. Use the following link to explore the OCFS Key Measures Dashboard. The primary contact for data requests is Mandy Milligan, Office of Child and Family Services: mandy.milligan@maine.gov

The Maine Prescription Monitoring Program (PMP) maintains a secure database that is implemented across the State of Maine to improve public health by providing data on controlled substance drug use information prior to providers prescribing or dispensing controlled substances. Data is submitted by Maine pharmacies, mail-service pharmacies, remote-dispensing pharmacies, and other dispensers including physicians and veterinarians. The primary contact for data requests is Jennifer Marlowe, PMP & IT Project Coordinator, Office of Behavioral Health: jennifer.marlowe@maine.gov

Maine Pretrial Services tracks data regarding Maine’s Co-Occuring Disorders Court, Family Treatment Drug Court, Adult Treatment Drug Court and other alternative sentencing programs. Data is reported to the Office of Behavioral Health and consists of program referrals, admissions, graduations, and discharges. The primary contact for data requests is info@mainepretrial.org.

Maine’s recovery data comes from several self-reporting organization including the Maine Association of Recovery Residences (MARR) and the Maine Recovery Hub. Data is reported through the Office of Behavioral Health. The primary contact for data requests is Michael Freysinger, Social Services Recovery Manager, Office of Behavioral Health: michael.freysinger@maine.gov

The Maine Statewide Epidemiology Outcome Workgroup (SEOW) provides data regarding substance misuse prevention planning. They provide data regarding substance misuse patterns and populations, establish substance abuse trends, detect emerging substances, and provide information for policy development and program planning. Use the following link to explore the Maine SEOW Dashboard. The primary contact for data requests is Tim Diomede, Research Analyst, Public Consulting Group: timothy.diomede@maine.gov

The National Survey on Drug Use and Health (NSDUH) is a nationwide survey that provides information on tobacco, alcohol, and drug use, mental health and other health-related issues. Information from NSDUH is used to support prevention and treatment programs, monitor substance use trends, estimate the need for treatment and inform public health policy.

NSDUH defines Illicit Drugs as marijuana/hashish, cocaine (including base), heroin, hallucinogens, inhalants, or any prescription drug used non-medically. Dependence, misuse, or abuse definitions are taken from the Diagnostic and Statistical Manual of Mental Disorders (DSM) and Serious Mental Illness is defined as a diagnosable mental, behavioral, or emotional disorder that meets the criteria found in the DSM and resulted in functional impairment that substantially interfered with or limited one or more major life activities.

Use the following link to explore the NSDUH website.

The Northern New England Poison Center (NNEPC) serves Maine, New Hampshire and Vermont. The NNEPC provides free, 24-hour poison emergency and information help line, available at 1-800-222-1222, by online chat or by texting POISON to 85511. The NNEPC serves the general public as well as health care professionals. The drug categories from NNEPC are as follows: alcohol includes alcohol-containing substances such as mouth wash and rubbing alcohol; opioids includes buprenorphine, codeine, fentanyl and fentanyl analogs, heroin, Hydrocodone, hydromorphone, Meperidine (Demerol), methadone, morphine, Oxycodone, propoxyphene, stomach opioids, tramadol, and other/unknown opioids; stimulants/street drugs include amphetamine, caffeine tablets, cocaine, cocaine base (crack), dextroamphetamine, ecstasy, marijuana and other cannabis, methamphetamine, other/unknown stimulants/street drugs; These data are only reflective of cases in which the NNEPC was contacted for consultation. The primary contact for data requests is Colin Smith, Data Requests and Website Maintenance Admin, Northern New England Poison Center: smithc12@mmc.org

The Overdose Detection Mapping Application Program provides near real-time suspected overdose surveillance data across jurisdictions to support public safety and public health efforts to mobilize an immediate response to a sudden increase, or spike in overdose events. Public health and community organizations can sign up for spike alerts to be aware and educate their constituents regarding rapid increases in overdoses occurring within their communities if there is a participating public safety department employing the software locally. The primary contact for data requests and spike alerts is Sybil Mazerolle, Substance-Use Disorder Program Manager, Office of Behavioral Health: sybil.mazerolle@maine.gov

After each National Prescription Drug Take Back Day the U.S. Department of Justice, Drug Enforcement Administration’s Diversion Control Division publishes the National Prescription Drug Take Back Day Collection Results. The National Prescription Drug Take Back Day aims to provide safe, convenient, and responsible means of disposing of prescription drugs, while also educating the general public about the potential for misuse of medications. Reports are published annually or semi-annually. Use the following link to access the DEA Diversion Website for National Prescription Drug Take Back Day.


Maine Drug Data Hub Metric Summary Table

This data metric summary table provides an index of data metrics located on the hub as well as an at-a-glance look at each of the metrics being tracked on the Maine Drug Data Hub. The metrics are divided into the five focus areas of the Maine Opioid Crisis Strategic Action Plan: Leadership, Prevention, Harm Reduction, Treatment, and Recovery. 

Each metric on the Maine Drug Data Hub is updated on a monthly, quarterly, or annual basis depending on when data reports are compiled and data are released. Located on the data table is the most recent time period for the metric, the most current provisional data, and the most current year-to-date totals. Hyperlinks are provided to direct users to metrics within the hub for further data exploration.

MetricFocus AreaAgencyLatest Data SetMost Recent DataYear-to-Date Total
Number of Overdose DeathsLeadershipOCMEQ4 2020124504
Deaths Due to Non-pharmaceutical fentanyl or fentanyl analogsLeadershipOCME2019259259
Grams of Drugs Seized by Maine Drug Enforcement AgencyPreventionMDEAFebruary 20211,4132,598
Pharmaceutical Dosage Units Seized by Maine Drug Enforcement AgencyPreventionMDEA20203,5243,524
Drug Arrests Made by Maine Drug Enforcement AgencyPreventionMDEA2020380380
Morphine Milligram Equivalents Prescribed in MainePreventionOBHQ1 2021180,825,744180,825,744
Opioid Prescriptions in MainePreventionOBHQ1 2021142,000142,000
Patients Prescribed Opioids PreventionOBHQ1 202163,00063,000
Doses of State-Supplied Naloxone DistributedHarm ReductionUMaineMarch 20216,79416,806
Total Enrollees in Syringe Access ProgramsHarm ReductionME CDC20195,5945,594
Total Number of Exchanges at Syringe Access ProgramsHarm ReductionME CDC201918,07918,079
Service referrals made by Syringe Access ProgramsHarm ReductionME CDC201917,37617,376
EMS Incidents Requiring Naloxone AdministrationHarm ReductionME EMS20201,3651,365
Suspected Drug Overdose in Maine Emergency Departments (Fatal and Nonfatal)Harm ReductionME CDCQ4 20208743,836
Mainers over the age of twelve suffering from substance-use disorderTreatmentNSDUH2016-20188.64%8.64%
MaineCare claims for substance-use disorderTreatmentOBH201922,08022,080
Mainers with substance-use disorder who did not receive treatmentTreatmentNSDUH2016-20188.04%8.04%
The number of Maine Department of Corrections clients receiving Medication-Assisted TreatmentTreatmentMDOC2019115115
Percent of Maine Department of Corrections clients who attended community treatment post incarceration TreatmentMDOC201984%84%
Percent of Maine Department of Corrections clients enrolled in Medication-Assisted Treatment who received naloxone at their releaseTreatmentMDOC2020100%100%
Substance-use education and prevention programs completed by Maine Department of Corrections clientsTreatmentMDOC20201,2081,208
Number of Recovery Community CentersRecoveryOBH20201313
Number of Deaths Caused by Cocaine or Methamphetamine Alone or in Combination with other DrugsLeadershipOCME2019157157
Number of Deaths Caused by Benzodiazepines Alone or in Combination with other DrugsLeadershipOCME20198484
Naloxone administrations and Reported Overdose Reversals by Law Enforcement, Public Health, EMS, and Harm Reduction ProgramsHarm ReductionUMaineMarch 2021360860
Cumulative Opioid Overdose Reversals Reported by Community PartnersHarm ReductionUMaineMarch 2021156383
Monthly Opioid Overdose Reversals Reported by Community PartnersHarm ReductionUMaineMarch 2021156383
Benzodiazepines Prescriptions in MainePreventionOBHQ1 2021101,409101,409
Patients Prescribed BenzodiazepinesPreventionOBHQ1 202152,25652,256
Syringes Distributed by Syringes Access ProgramsHarm ReductionME CDC20201,481,6791,481,679
Syringes Collected by Syringe Access ProgramsHarm ReductionME CDC20201,310,5241,310,524
Total Syringes Exchanged by Syringe Access ProgramsHarm ReductionME CDC20202,794,2232,794,223
Pounds of Prescription Drugs Collected at MDEA Take Back Day PreventionDEAApr 202127,34027,340
Suspected and Confirmed Monthly Fatal OverdosesLeadershipOCMEFebruary 202145100
Distribution of Monthly Drug Deaths by Maine CountyLeadershipOCMEFebruary 2021VariedVaried
Age Composition of Monthly Overdose DecedentsLeadershipOCMEFebruary 2021VariedVaried
Gender Composition of Monthly Overdose DecedentsLeadershipOCMEFebruary 2021VariedVaried
EMS Responding Alone to Fatal OverdosesLeadershipOCMEFebruary 202126
Law Enforcement Responding Alone to Fatal OverdosesLeadershipOCMEFebruary 2021819
EMS and Law Enforcement Co-responding to Fatal OverdosesLeadershipOCMEFebruary 20213579
Number of Monthly Fatal Overdoses Ruled an AccidentLeadershipOCMEFebruary 20214293
Number of Monthly Fatal Overdoses Ruled a SuicideLeadershipOCMEFebruary 202134
Number of Decedents Administered NaloxoneLeadershipOCMEFebruary 20211428
Number of Decedents Administered Naloxone by Bystanders OnlyLeadershipOCMEFebruary 202112
Number of Decedents Administered Naloxone by Law Enforcement OnlyLeadershipOCMEFebruary 202114
Number of Decedents Administered Naloxone by EMS OnlyLeadershipOCMEFebruary 20211118
Number of Decedents Administered Naloxone by Both EMS and Law EnforcementLeadershipOCMEFebruary 202101
Number of Decedents Administered Naloxone by Both EMS and a BystanderLeadershipOCMEFebruary 202112
Monthly Number of Nonfatal OverdosesLeadershipUMaineJanuary - February 2021variedvaried
Opiates prescribed electronically PreventionOBH2020566,686566,686
Opiates prescribed non-electronically PreventionOBH202065,37765,377
Number of Hits on Maine Drug Data HubLeadershipUMaineApril 202142,087140,936
EMS Response Calls for Overdoses (all drugs)Harm ReductionME EMSMarch 20219552,584
EMS Response Calls Where Naloxone Was Administered by CountyHarm ReductionME EMS2020VariousVarious
Number of buprenorphine prescriptionsTreatmentOBHFebruary 202027,907Not Applicable
Number of individuals admitted to Maine drug courtsRecoveryOBHQ1 20212626
Number of individuals not admitted to Maine drug courtsRecoveryOBHQ1 202177
Number of individuals graduating from Maine drug courtsRecoveryOBHQ1 20211616
EMS Incidents Requiring Naloxone Administration, Past 12 MonthsHarm ReductionME EMSMarch 2021145346
Number of residents admitted into MDOC institutions assessed as having SUD treatment needsTreatmentMDOC2020613613
Percent of residents admitted into MDOC institutions assessed as having SUD treatment needsTreatmentMDOC2020varied by sexvaried by sex
Number of MDOC residents transitioned to the community with a community treatment providerTreatmentMDOC2020532532
Number of MDOC residents active in treatment at a correctional facilityTreatmentMDOCDecember 2020186186
Number of individuals admitted to corrections with a primary sentence for a drug crimePreventionMDOC2020127127
Patients Prescribed StimulantsPreventionOBHQ1 202131,66331,663
Number of Stimulant PrescriptionsPreventionOBHQ1 202177,59477,594

Navigate the Data Hub